StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

Inside Cipla’s battle with ‘superbugs’ as antibiotic resistance rises in India

by Live mint | July 3, 2025 4:06 pm | Indian Stocks, Market, News

‘Superbugs’ render existing treatments ineffective and can worsen an infection, even causing death.

Recent Posts

  • SWL Miner Unveils New Era of Passive Crypto Income
  • Bitcoin, Ethereum, XRP Need Not Worry About Summer Blues As Long As This Critical Support Holds, Trader Says
  • Optimove on Pace to More than Double New iGaming Clients in 2025, Fueled by Optimove Ignite+ and Gamification Innovation
  • Fastenal Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
  • Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved